News
PlushCare, a direct-to-consumer telemedicine service that originally focused on acute and urgent care, has partnered with Thermo Fisher Scientific to add allergy testing to its offerings.
Helix has closed a $200 million financing round and said it plans to expand its personal genomics marketplace to accelerate consumer adoption of genomics.
Pear Therapeutics has inked a deal with pharma company Novartis to work together on the development of two digital therapeutics for multiple sclerosis and schizophrenia.
Qualcomm Life announced an exclusive licensing agreement with AlertWatch, creator of an FDA-cleared intelligence care software that assists in the care of patients in the operating room.
At HIMSS18, Philips plans to announce several new additions to its line of connected care products.
It’s hard to be a printer and typewriter company in 2018.
Woebot Labs, a mental health artificial intelligence platform, just landed $8 million in Series A funding with New Enterprise Associates leading and Andrew Ng’s AI Fund participating.
Correction: A previous version of this article misstated Watson's contributions to the Teladoc platform.
Being a new parent can be scary—even figuring out a baby’s eating schedule can be tough.
On Apple’s most recent earnings call, CEO Tim Cook didn’t talk much about the company’s various healthcare overtures.